EBITDA
Lincoln Pharmaceuticals Ltd Reports 26.66% Rise in Profit Rs. 19.01 Crore
RIL Posted Record Quarterly Consolidated EBITDA At ₹ 40179 Cr with 45.8% YoY Growth
Adani Transmission Posted Robust year registering 50% growth in EBITDA and 26% growth in PAT